Capex / revenue moved 584 bp higher
Capex / revenue changed +584 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
0.83%→6.67%4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ODYS financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure increased 833.3%
Capital expenditure changed +833.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$3,000→$28,0004 prior comparisons
Cash & equivalents decreased 47.7%
Cash & equivalents changed -47.7% from the comparable as-filed period.
$32.9M→$17.2M3 prior comparisons
Operating margin moved 14716 bp higher
Operating margin changed +14716 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
-1225.97%→-1078.81%4 prior comparisons
Stock-based compensation decreased 46.5%
Stock-based compensation changed -46.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$845,000→$452,0004 prior comparisons
Gross profit increased 19.5%
Gross profit changed +19.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$133,000→$159,0004 prior comparisons
Revenue increased 16.0%
Revenue changed +16.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$362,000→$420,0004 prior comparisons
Free-cash-flow proxy decreased 7.5%
Free-cash-flow proxy changed -7.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
-$4.2M→-$4.5M4 prior comparisons
Gross margin moved 112 bp higher
Gross margin changed +112 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
36.74%→37.86%4 prior comparisons
Net income decreased 6.1%
Net income changed -6.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
-$4.1M→-$4.3M4 prior comparisons
Operating cash flow decreased 6.9%
Operating cash flow changed -6.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
-$4.2M→-$4.5M4 prior comparisons
Operating income decreased 2.1%
Operating income changed -2.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
-$4.4M→-$4.5M4 prior comparisons
Research & development decreased 4.9%
Research & development changed -4.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$2.4M→$2.2M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.